Geron Corporation
(NASDAQ : GERN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.26%80.040.9%$592.67m
CELGCelgene Corporation
-1.35%136.981.1%$550.87m
AMGNAmgen Inc.
-0.08%186.051.1%$449.49m
BIIBBiogen Inc.
0.22%345.231.2%$387.34m
REGNRegeneron Pharmaceuticals, Inc.
-1.30%436.832.7%$313.83m
ALNYAlnylam Pharmaceuticals, Inc
-1.90%116.4410.7%$251.43m
VRTXVertex Pharmaceuticals Incorporated
-0.38%154.471.9%$220.62m
INCYIncyte Corporation
-0.40%115.182.5%$207.14m
ALXNAlexion Pharmaceuticals, Inc.
-1.91%140.431.9%$178.57m
ILMNIllumina, Inc.
-0.23%206.013.5%$139.56m
EXELExelixis, Inc.
-1.87%27.776.5%$132.90m
CLVSClovis Oncology, Inc.
-2.40%79.3716.5%$121.69m
BLUEBluebird Bio, Inc.
-1.23%138.4817.3%$116.67m
SRPTSarepta Therapeutics, Inc.
-0.18%51.6316.9%$109.83m
BMRNBioMarin Pharmaceutical Inc.
-4.42%89.414.4%$98.92m

Company Profile

Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.